SMS Pharmaceuticals Limited

Web: smspharma.com NSE: SMSPHARMA BSE: 532815 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

388 14(3%)

Volume

2L as on 23, Jun

Open

231

High

235

Low

230

374

VWAP

381

52 Week High

448

52 Week Low

231

Viand Research Rating

Quality Score

33/100

Growth Score

44/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,631

No. of Shares

9.37

P/E

37.68

P/B

3.88

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

10.29

ROCE

Profit Growth

Listing Date

28-Feb-07

Promoter Holding

68.07%

FII Holding

0.65%

DII Holding

2.83%

Price Chart

Price Performance

1 Week1%

1 Month0%

3 Months3%

6 Months10%

1 Year10%

YTD10%

Moving Average

5 Day SMA377

10 Day SMA378

20 Day SMA373

30 Day SMA382

50 Day SMA395

61 Day SMA394

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	388	377	385	388
Resistance 2	385	376	381	384
Resistance 1	380	375	379	379
Pivot Point	376	374	376	376
Support 1	371	374	373	370
Support 2	367	373	371	367
Support 3	362	372	367	361

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 68.07%	(0.01) 68.07%	(0.01) 68.07%	(1.81) 68.07%	(0.01) 66.27%	(1.61) 66.27%	(0.01) 64.67%	(0.01) 64.67%	(0.01) 64.67%	(0.41) 64.67%	(0.01) 64.32%	(0.01) 64.32%	(0.01) 64.32%	(0.11) 64.29%	(0.01) 64.17%	(0.01) 64.17%	(-3.11) 64.17%	(0.01) 67.29%	(0.01) 67.29%	(0.01) 67.29%
FIIs	(0.31) 0.65%	(0.31) 0.31%	(-0.21) 0.04%	(0.31) 0.28%	(-0.11) 0.03%	(-0.21) 0.08%	(-0.21) 0.31%	(0.31) 0.52%	(0.01) 0.18%	(-0.41) 0.17%	(0.01) 0.59%	(-0.11) 0.60%	(0.11) 0.67%	(0.01) 0.59%	(0.01) 0.59%	(0.01) 0.59%	(0.01) 0.63%	(0.01) 0.61%	(-0.31) 0.65%	(0.01) 0.94%
DIIs	(-0.21) 2.83%	(-0.21) 3.02%	(0.31) 3.21%	(-0.21) 2.88%	(0.61) 3.03%	(-0.11) 2.43%	(0.01) 2.55%	(0.41) 2.55%	(0.21) 2.13%	(2.01) 1.98%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	28.45%	28.60%	28.69%	28.77%	30.68%	31.23%	32.47%	32.27%	33.03%	33.18%	35.10%	35.07%	35.01%	35.12%	35.23%	35.23%	35.20%	32.10%	32.06%	31.76%
No. of Shareholders	31,489	32,397	34,378	34,157	33,652	35,332	34,973	33,136	31,780	30,140	25,341	25,246	24,653	25,537	26,526	26,491	26,638	27,516	24,959	24,608

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	207	238	210	242	196	248	173	197	164	246	161	167	135	149	149	159	64	61	121	175	163
Sales Growth % (YoY)	5.6%	-4.1%	21.4%	23.2%	19.2%	1%	7.4%	18.1%	21.5%	64.5%	8.5%	4.5%	110.2%	144.4%	22.7%	-8.7%	-60.5%	-64.3%	-18.6%	34.2%	44.5%
Sales Growth % (QoQ)	-13%	13.3%	-13.2%	23.5%	-21%	43.4%	-12.2%	20.1%	-33.3%	52.8%	-3.6%	23.7%	-9.4%	-	-6.3%	148.4%	4.9%	-49.6%	-30.9%	7.4%	-
Expenses	166	198	167	194	157	207	140	165	131	212	132	139	109	126	130	146	65	65	94	128	119
Operating Profit	41	40	44	48	39	41	33	31	34	34	29	28	26	23	19	14	-1	-4	27	47	45
OPM %	20	17	21	20	20	16	19	16	20	14	18	17	19	16	12	9	-1	-7	22	27	27
Other Income	2	3	4	1	1	1	2	1	1	2	1	1	1	1	2	1	1	0	2	1	1
Interest	6	5	6	6	6	5	4	5	5	6	6	6	6	6	6	5	5	4	5	5	5
Depreciation	10	10	10	10	10	9	9	9	8	8	8	8	8	8	8	8	8	8	8	8	8
Profit before tax	27	27	31	34	24	29	22	20	22	22	17	15	13	11	7	1	-13	-16	16	35	33
Tax %	26	23	26	26	23	30	24	29	25	26	26	21	31	24	21	13	-20	-154	37	29	29
Net Profit	21	33	23	25	20	20	18	14	16	17	11	12	9	6	4	-2	-13	6	9	23	24
Net Profit Growth % (QoQ)	-36.4%	43.5%	-8%	25%	-	11.1%	28.6%	-12.5%	-5.9%	54.5%	-8.3%	33.3%	50%	50%	300%	84.6%	-316.7%	-33.3%	-60.9%	-4.2%	-
Net Profit Growth % (YoY)	5%	65%	27.8%	78.6%	25%	17.6%	63.6%	16.7%	77.8%	183.3%	175%	700%	169.2%	-	-55.6%	-108.7%	-154.2%	-	-	-	-
TTM Net Profit	102	101	88	83	72	68	65	58	56	49	38	31	17	-5	-5	0	25	62	56	47	0
EPS in Rs	2.23	3.49	2.51	2.7	2.31	2.29	2.15	1.66	1.95	2.04	1.36	1.38	1.1	0.73	0.44	-0.24	-1.51	0.73	1.06	2.72	2.78

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2007
Sales	887	783	709	522	520	563	412	465	463	438	611	193
Sales Growth %	13.3%	10.4%	35.9%	0.4%	-7.7%	36.7%	-11.4%	0.5%	5.6%	-28.3%	-	-
Expenses	716	644	593	467	405	442	332	375	369	363	522	145
Operating Profit	171	139	117	55	115	121	80	90	93	75	89	47
OPM %	19	18	16	10	22	22	19	19	20	17	15	25
Other Income	8	6	4	5	5	3	5	3	2	1	4	5
Interest	23	19	24	22	19	11	12	12	15	16	17	8
Depreciation	40	34	32	32	32	22	22	19	20	19	19	5
Profit before tax	117	92	66	5	68	91	51	62	60	42	56	40
Tax %	25	27	26	28	1	33	36	34	33	14	26	36
Net Profit	102	69	50	-7	62	63	32	40	32	28	41	25
Net Profit Growth %	47.8%	38%	814.3%	-111.3%	-1.6%	96.9%	-20%	25%	14.3%	-31.7%	64%	-
EPS in Rs	10.89	7.8	5.88	-0.83	7.35	7.38	3.73	4.73	3.75	3.36	4.83	2.55
Dividend Payout %	4	5	7	-36	4	4	7	5	7	6	4	8

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2007
Cash from Operating Activity	59	82	50	22	45	90	40	50	32	73	61	14
Cash from Investing Activity	-131	-123	-52	-30	-27	-152	-43	-35	-17	-39	-97	-32
Cash from Financing Activity	76	47	31	-32	-12	92	-2	-13	-15	-33	27	107
Net Cash Flow	4	5	29	-39	6	31	-5	2	0	1	-9	89

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2007
Equity Capital	9	9	9	8	8	8	8	8	8	8	8	8	8	10
Reserves	776	720	631	555	528	452	462	402	340	313	276	246	285	182
Borrowings	365	324	311	285	281	254	263	255	157	144	146	149	204	73
Other Liabilities	212	223	202	286	217	165	126	147	103	93	72	89	158	64
Total Liabilities	1362	1276	1153	1135	1034	880	860	812	608	559	503	493	656	329
Fixed Assets	534	517	533	426	437	412	438	457	280	281	279	290	370	69
CWIP	122	54	35	94	30	33	11	7	42	18	8	8	13	15
Investments	26	14	12	11	11	11	22	27	26	27	28	29	21	0
Other Assets	681	692	573	603	556	424	389	321	259	232	187	166	252	245
Total Assets	1362	1276	1153	1135	1034	880	860	812	608	559	503	493	656	329

Delivery

Delivery Data: SMSPHARMA

#	Date	349 25% 438	Value (Cr)	Q/T 47	Del 41	Del 15
1	4-Sep	392	18	42	41	7
2	3-Sep	374	2	32	54	1
3	2-Sep	373	7	32	43	3
4	1-Sep	368	3	34	53	2
5	31-Aug	372	17	47	49	8
6	28-Aug	356	5	38	57	3
7	27-Aug	362	6	43	57	3
8	26-Aug	358	3	38	62	2
9	25-Aug	357	6	43	56	3
10	24-Aug	354	5	42	60	3
11	21-Aug	357	5	42	57	3
12	20-Aug	356	4	51	62	2
13	19-Aug	356	4	47	65	2
14	18-Aug	359	5	39	60	3
15	17-Aug	358	5	42	66	3
16	14-Aug	361	5	48	69	3
17	13-Aug	365	5	43	58	3
18	12-Aug	370	9	56	46	4
19	11-Aug	379	7	48	51	4
20	10-Aug	372	4	31	46	2
21	7-Aug	378	21	42	42	9
22	6-Aug	357	6	40	68	4
23	5-Aug	365	5	43	55	3
24	4-Aug	364	9	45	49	4
25	3-Aug	364	11	42	58	6
26	31-Jul	374	9	39	51	5
27	30-Jul	375	13	33	59	8
28	29-Jul	397	9	33	47	4
29	28-Jul	381	4	32	65	3
30	27-Jul	392	4	25	47	2
31	24-Jul	381	2	24	53	1
32	23-Jul	385	6	46	66	4
33	22-Jul	387	5	37	62	3
34	21-Jul	388	2	27	48	1
35	20-Jul	384	2	32	53	1
36	17-Jul	388	5	33	51	2
37	16-Jul	387	5	37	53	3
38	15-Jul	392	5	32	66	3
39	14-Jul	399	17	48	60	10
40	13-Jul	400	23	30	74	17
41	10-Jul	403	16	50	58	9
42	9-Jul	407	15	52	67	10
43	8-Jul	403	13	41	59	8
44	7-Jul	424	13	31	39	5
45	6-Jul	420	6	41	54	3
46	3-Jul	421	7	54	50	4
47	2-Jul	418	15	43	28	4
48	1-Jul	409	71	70	23	16
49	30-Jun	413	325	63	9	28
50	29-Jun	381	7	55	59	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,631c	138c	3.95
03-Sep	3,493c	28c	0.80
01-Sep	3,465c	48c	1.36
31-Aug	3,513c	173c	5.19
26-Aug	3,340c	38c	1.13
25-Aug	3,302c	13c	0.40
24-Aug	3,315c	7c	0.21
21-Aug	3,322c	17c	0.52
19-Aug	3,340c	60c	1.76
18-Aug	3,400c	52c	1.55
17-Aug	3,348c	44c	1.28
14-Aug	3,391c	111c	3.18
13-Aug	3,503c	0	0
12-Aug	3,503c	15c	0.43
11-Aug	3,518c	15c	0.41
10-Aug	3,503c	137c	4.08
06-Aug	3,366c	36c	1.06
04-Aug	3,402c	7c	0.21
03-Aug	3,409c	98c	2.80
31-Jul	3,507c	58c	1.62
30-Jul	3,565c	126c	3.43
29-Jul	3,691c	125c	3.51
28-Jul	3,566c	73c	1.99
27-Jul	3,639c	0	0

Stock Checklist

Price is above from 52 week high low average: 72%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 6 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹115 Cr · 0 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	4	0.17%	-0.89%	114.5
Bandhan Mutual Fund	2	0.10%	-	0

SMS Pharmaceuticals Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements